PSYBF OTC
PsyBio Therapeutics Corp
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -90.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$50K
+96.8% ▲
Operating Income
-$4M
+52.0% ▲
Net Income
-$5M
+55.7% ▲
EPS (Diluted)
$-0.04
+58.0% ▲
EBITDA
-$5M
+52.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $2M | $2M | $50K |
| Gross Profit | $0 | $0 | -$2M | -$2M | -$50K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $55K | $623K | $390K |
| SG&A Expenses | $21K | $39K | $5M | $9M | $4M |
| Operating Expenses | $21K | $39K | $5M | $7M | $4M |
| Operating Income | -$21K | -$39K | -$6M | -$9M | -$4M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $21K |
| Income Before Tax | -$21K | -$16K | -$6M | -$11M | -$5M |
| Tax Expense | $0 | $0 | $0 | $1M | $0 |
| Net Income | -$21K | -$16K | -$6M | -$11M | -$5M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $0.00 | $-0.20 | $-0.10 | $-0.04 |
| EBITDA | -$21K | $156K | $0 | -$10M | -$5M |
| Shares Outstanding | 2M | 0 | 32M | 107M | 112M |